An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitus

Diabetic Medicine

Volumn 25, Issue 2, 2008, Pages 228-231

  Diedrichs, H ^a   Pfister, R ^a   Hagemeister, J ^a   Muller Ehmsen J ^a   Frank, K F ^a   Hopp H W ^a   Erdmann, E ^a   Schneider, C A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Coronary artery disease; Diabetes mellitus; Glycated haemoglobin; Percutaneous coronary intervention; Restenosis

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORONARY STENT; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MOLECULAR DYNAMICS; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; RESTENOSIS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; STENTS;

EID: 39749195580     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02320.x     Document Type: Article

References (12)

1. Radke PW, Voswinkel M, Reith M, Kaiser A, Haager PK, Hanrath P et al. Relation of fasting insulin plasma levels to restenosis after elective coronary stent implantation in patients without diabetes mellitus. Am J Cardiol 2004 93 : 639 641.
2. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997 96 : 1366 1369.
3. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004 43 : 8 14.
4. 1c to rate of major adverse cardiac events in non-diabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol 2003 92 : 1282 1286.
5. Gronenschild E, Janssen J, Tijdens F. CAAS II: a second-generation system for offline and online quantitative coronary angiography. Cathet Cardiovasc Diagn 1994 33 : 61 75.
6. Schneider CA, Voth E, Moka D, Baer FM, Melin J, Bol A et al. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol 1999 34 : 1005 1011.
7. 1c. Cardiovasc Revasc Med 2007 8 : 15 20.
8. 1c. Diabetes Care 2003 26 : 881 885.
9. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002 25 : 275 278.
10. Ceriello A. The postprandial state and cardiovascular disease: relevance to diabetes mellitus. Diab Metab Res 2000 16 : 125 132.
11. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K et al. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia 1998 41 : 706 712.
12. Marx N, Wöhrle J, Nusser T, Walcher D, Rinker A, Hombach V et al. Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in non-diabetic patients. Circulation 2005 112 : 2792 2798.